Japan's Weight-Loss Drug Craze Sparks Illegal Sales

In Japan, the diabetes medication Mounjaro has seen a surge in popularity among young people, primarily for its weight-loss properties. This trend has led to a concerning rise in unauthorized private sales, particularly via social media platforms.

Osaka Prefectural Police recently forwarded papers on three individuals to prosecutors. They are suspected of violating pharmaceutical safety laws by selling Mounjaro without authorization through social media. The accused, aged 22 to 35, reportedly admitted to the sales, aiming to earn extra income. They allegedly obtained the drug through social media purchases or via health insurance prescriptions.

Mounjaro is approved for Type 2 diabetes but is also marketed for "medical dieting," with clinics offering it through self-paid treatments. This has lowered access barriers, but private sales remain illegal and dangerous. Health authorities and medical professionals warn of severe side effects and the risk of scarcity for genuine diabetes patients.

The Tokyo Metropolitan Government has issued numerous warnings about online drug sales, with a significant portion concerning diabetes drugs like Mounjaro. Medical experts stress the importance of obtaining such medications only through proper doctor consultations, warning against accepting them from unauthorized sources.